Established Firm Harding Loevner Enters ETF Market With LOEV for International Investors
Established Firm Harding Loevner Enters ETF Market With LOEV for International Investors
Michael WilliamsThu, July 23, 2026 at 7:41 PM UTC
0
tadamichi / Shutterstock.comQuick Read -
LOEV actively screens developed international markets for quality-growth companies that are financially sound, fast-growing, and competitively strong across at least 10 countries.
LOEV targets names like ASML and NVO but charges 0.70%, which is over 20 times more than Vanguard's passive international rival at 0.03%.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Novo Nordisk didn't make the cut. Grab the names FREE today.
Harding Loevner has entered the ETF market with the International Developed Markets Select Equity ETF (NYSEARCA:LOEV), an actively managed fund that buys stocks of companies based in developed markets outside the United States. According to the fund's prospectus dated June 12, 2026, LOEV lists on NYSE Arca and is issued by Harding, Loevner Funds, Inc., the fund arm of the Bridgewater, New Jersey investment firm that has spent decades running mutual funds and separately managed accounts for institutions.
The fund carries a management fee of 0.70%, with 0.00% in other expenses, for a total annual operating expense of 0.70%. On a $10,000 investment, that works out to about $70 a year. As of July 21, 2026, LOEV traded at $15.52, with only a handful of trading days behind it so far.
What the Fund Does
LOEV is actively managed, meaning a team at Harding Loevner picks the holdings rather than tracking an index. According to the prospectus, the managers conduct fundamental research to identify companies that are "well managed, financially sound, fast growing, and strongly competitive, and whose shares are reasonably priced relative to estimates of their value." That is a quality-growth style: owning durable businesses at prices the managers view as reasonable, rather than chasing whatever is cheapest or most in favor.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Novo Nordisk didn't make the cut. Grab the names FREE today.
The fund's stated benchmark is the MSCI World ex US Net (USD) index, and the portfolio is diversified across geography, industry, currency, and market capitalization, normally holding stocks across at least 10 countries. Harding Loevner has not yet published LOEV's full holdings, but the kinds of large developed-market names that fit this universe include ASML Holding (NASDAQ:ASML) in the Netherlands, Novo Nordisk (NYSE:NVO) in Denmark, SAP (NYSE:SAP) in Germany, and Shopify (NASDAQ:SHOP) in Canada.
Nothing exotic sits under the hood. There is no leverage, no options overlay, no crypto exposure, and no single-stock concentration. The predecessor portfolio's turnover rate was 28%, which points to a patient, low-churn approach if the ETF follows the same playbook.
Advertisement
Why It Exists and How It Stacks Up
Harding Loevner has been in business since 1989 and managed approximately $40.9 billion in assets as of December 31, 2025. The firm is known primarily among advisors and institutions for its international and global equity strategies. Wrapping one of those strategies in an ETF gives everyday investors access to the approach with the trading flexibility and typical tax efficiency of the ETF structure.
The competitive picture is a study in trade-offs. The largest passive rival, the Vanguard FTSE Developed Markets ETF, charges a rock-bottom expense ratio of 0.03%, and the iShares Core MSCI EAFE and Schwab International Equity funds sit in the same low-cost neighborhood. LOEV's 0.70% fee is materially higher. That extra cost buys active stock selection and Harding Loevner's quality-growth screen, and it is up to investors to decide whether they think that lens will beat a plain index over time.
Who It Might Suit, and the Risks
The fund is designed for investors who want dedicated exposure to developed international markets and prefer an actively managed approach over broad-index tracking. It could fit as the international-equity sleeve of a diversified portfolio, alongside U.S. and emerging-markets holdings.
The caveats deserve serious weight. LOEV has no ETF performance history to judge, only two trading days of price data as of this writing. New ETFs often launch with small assets and wide bid-ask spreads, and funds that fail to gather assets sometimes close. The prospectus also flags investment style risk, noting that a quality-growth approach can lag when markets reward value or high current dividends instead. Currency swings, foreign-market volatility, and concentration in a manager's stock picks are all part of the package.
For now, the things worth watching are how quickly LOEV attracts assets, how tightly it trades, and whether Harding Loevner's active picks can justify the fee gap versus penny-cheap index rivals over its first full year.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Novo Nordisk didn't make the cut. Grab the names FREE today.
Contact editorial@247wallst.com for any questions or corrections.
Source: “AOL Money”
